KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 38 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $25,000 | -3.8% | 53,635 | 0.0% | 0.00% | – |
| Q1 2015 | $26,000 | -78.7% | 53,635 | -24.1% | 0.00% | – |
| Q4 2014 | $122,000 | -5.4% | 70,635 | -15.5% | 0.00% | – |
| Q3 2014 | $129,000 | -24.1% | 83,635 | +12.1% | 0.00% | – |
| Q2 2014 | $170,000 | -14.6% | 74,635 | +1.4% | 0.00% | – |
| Q1 2014 | $199,000 | -10.0% | 73,635 | +47.3% | 0.00% | – |
| Q4 2013 | $221,000 | -45.0% | 50,000 | -43.8% | 0.00% | -100.0% |
| Q3 2013 | $402,000 | +197.8% | 89,000 | +270.8% | 0.00% | – |
| Q2 2013 | $135,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,632,928 | $14,902,000 | 6.60% |
| DAFNA Capital Management LLC | 79,834 | $452,000 | 0.66% |
| Lehman Brothers Holdings Inc. | 1,067,059 | $6,040,000 | 0.28% |
| WALL STREET ASSOCIATES | 413,000 | $2,338,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 265,112 | $1,501,000 | 0.20% |
| PRIMECAP MANAGEMENT CO/CA/ | 3,681,675 | $20,838,000 | 0.03% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 93,561 | $530,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 69,379 | $393,000,000 | 0.01% |
| PRINCIPAL FINANCIAL GROUP INC | 300,000 | $1,698,000 | 0.00% |
| FMR LLC | 2,307,829 | $12,223,000 | 0.00% |